- Home
- HURA vs HYPR Comparison
HURA vs HYPR Comparison
Compare HURA & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HURA
- HYPR
- Stock Information
- Founded
- HURA 2009
- HYPR 2014
- Country
- HURA United States
- HYPR United States
- Employees
- HURA N/A
- HYPR N/A
- Industry
- HURA
- HYPR Medical Specialities
- Sector
- HURA
- HYPR Health Care
- Exchange
- HURA Nasdaq
- HYPR Nasdaq
- Market Cap
- HURA 131.8M
- HYPR 137.5M
- IPO Year
- HURA N/A
- HYPR N/A
- Fundamental
- Price
- HURA $2.29
- HYPR $1.27
- Analyst Decision
- HURA Strong Buy
- HYPR Strong Buy
- Analyst Count
- HURA 2
- HYPR 3
- Target Price
- HURA $11.50
- HYPR $1.28
- AVG Volume (30 Days)
- HURA 181.8K
- HYPR 1.1M
- Earning Date
- HURA 11-13-2025
- HYPR 11-11-2025
- Dividend Yield
- HURA N/A
- HYPR N/A
- EPS Growth
- HURA N/A
- HYPR N/A
- EPS
- HURA N/A
- HYPR N/A
- Revenue
- HURA N/A
- HYPR $10,797,000.00
- Revenue This Year
- HURA N/A
- HYPR $12.92
- Revenue Next Year
- HURA N/A
- HYPR $32.10
- P/E Ratio
- HURA N/A
- HYPR N/A
- Revenue Growth
- HURA N/A
- HYPR N/A
- 52 Week Low
- HURA $1.80
- HYPR $0.53
- 52 Week High
- HURA $7.20
- HYPR $2.22
- Technical
- Relative Strength Index (RSI)
- HURA 39.99
- HYPR 43.13
- Support Level
- HURA $2.16
- HYPR $1.21
- Resistance Level
- HURA $2.61
- HYPR $2.22
- Average True Range (ATR)
- HURA 0.13
- HYPR 0.19
- MACD
- HURA -0.02
- HYPR -0.08
- Stochastic Oscillator
- HURA 25.51
- HYPR 6.93
About HURA TuHURA Biosciences Inc. Common Stock
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.
About HYPR Hyperfine Inc.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.